Novo Nordisk (NVO) ADRs are down after the company said it had signed a deal with Emisphere Technologies (EMIS) to use that firm's technology to develop an oral insulin pill, according to a company statement. Currently, there are
From FNNO.com, this is the Financial News Network. I’m Cleo
Stiller-Farrell and this is your Midweek Market Wrap Up. The British
Bankers’ Association, which has the supervisory role of setting the
influential Libor rates, announced that it would be willing to give up
its...
